Signaling Pathways in the Pathogenesis of Barrett's Esophagus and Esophageal Adenocarcinoma

Int J Mol Sci. 2023 May 26;24(11):9304. doi: 10.3390/ijms24119304.

Abstract

Barrett's esophagus (BE) is a premalignant lesion that can develop into esophageal adenocarcinoma (EAC). The development of Barrett's esophagus is caused by biliary reflux, which causes extensive mutagenesis in the stem cells of the epithelium in the distal esophagus and gastro-esophageal junction. Other possible cellular origins of BE include the stem cells of the mucosal esophageal glands and their ducts, the stem cells of the stomach, residual embryonic cells and circulating bone marrow stem cells. The classical concept of healing a caustic lesion has been replaced by the concept of a cytokine storm, which forms an inflammatory microenvironment eliciting a phenotypic shift toward intestinal metaplasia of the distal esophagus. This review describes the roles of the NOTCH, hedgehog, NF-κB and IL6/STAT3 molecular pathways in the pathogenesis of BE and EAC.

Keywords: Barrett’s esophagus; carcinogenesis; dysplasia; esophageal adenocarcinoma; inflammatory signaling pathways; intestinal metaplasia; mutational load; p53.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / complications
  • Adenocarcinoma* / genetics
  • Barrett Esophagus* / metabolism
  • Esophageal Neoplasms* / genetics
  • Esophageal Neoplasms* / metabolism
  • Humans
  • Signal Transduction
  • Tumor Microenvironment

Supplementary concepts

  • Adenocarcinoma Of Esophagus

Grants and funding

This research received no external funding.